Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
Bisacodyl is indicated to relieve occasional constipation and irregularity.
Policlinico Umberto I, Roma, Italy
Synergy Research Site, St-Romuald, Quebec, Canada
Motility Laboratory, Division of Pediatric Gastroenterology, Hepatology and Nutrition at the James Whitcomb Riley Hospital for Children,, Indianapolis, Indiana, United States
Ospedale S.Maria delle Croci, Ravenna, RA, Italy
Alessandro Mussetto, Ravenna, RA, Italy
Oslo Universitetssykehus, Oslo, Norway
Hospital de Sabadell, Sabadell, Barcelona, Spain
European Institute of Oncology, Milan, Italy
Hotel Dieu Hospital, Kingston, Ontario, Canada
St Joseph Hospital, Hamilton, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.